You are viewing: South Korea Lateral Flow Assays Market analysis
Part of: Lateral Flow Assays Market (Global)

The South Korea Lateral Flow Assays Market was valued at $71.3 Million in 2025 and projected to reach to $96 Million by 2030, representing a compound annual growth rate of 6.1%. South Korea's lateral flow assays market is poised for steady growth through 2030, driven by the country's advanced healthcare infrastructure, high diagnostic awareness, and increasing demand for rapid testing solutions.

South Korea Lateral Flow Assays Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Lateral Flow Assays Market Trends and Insights

  • South Korea's advanced healthcare infrastructure and strong diagnostic capabilities position the country as a key player in the Asia Pacific lateral flow assays sector.
  • The market in South Korea is driven by increasing demand for rapid point-of-care testing, rising prevalence of infectious diseases, and growing adoption of home-based diagnostic solutions across the forecast period. South Korea's emphasis on healthcare innovation and regulatory support for diagnostic technologies further accelerates market penetration.
  • The country's aging population and heightened focus on preventive healthcare create sustained demand for accessible, cost-effective testing solutions.
  • South Korea's lateral flow assays market benefits from robust manufacturing capabilities and export opportunities, positioning it as a regional hub for diagnostic device development and distribution through 2030..

Key Market Statistics

  • CAGR (2025-2030) 6.1% CAGR
  • Market Size, 2025 ~USD 71.3 Million
  • Forecast, 2030 ~USD 96 Million
  • Country South Korea

South Korea Lateral Flow Assays Market Overview

Market Valuation :

South Korea's lateral flow assays market is valued at USD 71.3 million in 2025, with projected growth to USD 96.0 million by 2030, representing a steady CAGR of 6.1%.

Advanced Healthcare Infrastructure :

South Korea's sophisticated healthcare system and high diagnostic adoption rates position it as a leading market in the Asia Pacific region for lateral flow assay technologies and innovations.

Regulatory Environment :

South Korea's stringent regulatory framework and quality standards drive demand for certified lateral flow assay products, ensuring market growth through premium-quality diagnostic solutions.

Point-of-Care Testing Expansion :

Increasing adoption of point-of-care testing in South Korean clinics, hospitals, and home healthcare settings is accelerating lateral flow assay market penetration across diverse medical applications.

South Korea Lateral Flow Assays Market Dynamics

  • The market benefits from strong government healthcare investments and a population with high healthcare spending capacity.
  • Technological advancements in assay sensitivity and specificity, coupled with expanding applications in infectious disease detection and chronic disease management, will support market expansion.
  • South Korea's position as a medical device innovation hub further strengthens its lateral flow assays sector, attracting both domestic and international manufacturers seeking to establish regional presence..

Market Ecosystem

logo-mobile

LATERAL FLOW ASSAYS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides rapid lateral flow diagnostics through its BinaxNOW and other rapid-testing platforms, including digitally read LFA formats such as BinaxNOW Influenza A & B Card 2 for the DIGIVAL platform. Enables rapid decentralized testing, supports objective digital interpretation, and provides results within minutes for point-of-care and other testing settings.
company logo
Develops lateral flow immunochromatographic tests for rapid diagnostics and is expanding access to large-scale LFA manufacturing through its strategic relationship with Sapphiros. Roche's SARS-CoV-2 Rapid Antigen Test 2.0 also incorporates digitally readable test identification. Supports rapid decentralized testing, enables digital traceability of individual tests, and strengthens access to scalable LFA manufacturing capacity.
company logo
Through Abcam, provides LFA-related assay development tools, including a Universal Lateral Flow Assay Kit and antibody-conjugation technologies specifically applicable to LFA development. Supports LFA assay development and optimization by enabling antibody labeling, conjugation with gold/fluorescent nanoparticles, and reproducible test development.
company logo
Provides the BD Veritor Plus System, combining a rapid point-of-care analyzer with lateral-flow-based assays for respiratory infections including influenza A/B, RSV and Group A Strep. Provides rapid, objective digital results, supports decentralized testing, and enables multiple assays on a common point-of-care platform.
company logo
Offers QUICKVUE rapid lateral-flow tests and the SOFIA platform, which uses fluorescent immunoassay/lateral-flow technology for rapid point-of-care testing across infectious and other diagnostic applications. Enables fast testing in point-of-care and laboratory settings, while SOFIA provides automated and objective interpretation to improve testing efficiency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Key Takeaways

  • South Korea's lateral flow assays market is valued at USD 71.3 million in 2025 and expected to reach USD 96.0 million by 2030.
  • South Korea demonstrates a 6.1% CAGR, reflecting steady growth driven by point-of-care testing demand and healthcare modernization.
  • South Korea's aging demographic and preventive healthcare focus create sustained demand for rapid diagnostic solutions.
  • South Korea's manufacturing expertise and regulatory environment position it as a regional leader in diagnostic device innovation and export.

Lateral Flow Assays Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment SEXUALLY TRANSMITTED INFECTION TESTING (Disease Type)
Forecast Period 2025–2030
Growth Rate CAGR of 8% from 2025 to 2030
Largest Segment KITS & REAGENTS (Product)
Market Size Base Year (Billions) ~USD 8.52 (2025)
Revenue Forecast (Billions) ~USD 12.52 (2030)
Segments Covered Product, Application, Type, Disease Type, Technique

South Korea Lateral Flow Assays Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

  • Kits & Reagents
  • Readers

By Application

  • Clinical Testing
  • Drug Development & Quality Testing
  • Food Safety & Environmental Testing
  • Veterinary Diagnostics

By Type

  • Bnp Or Nt-Probnp Testing
  • Cardiac Marker Testing
  • Chlamydia
  • Cholesterol/Lipid Profile
  • Ck-Mb Testing
  • D-Dimer Testing
  • Drugs Of Abuse Testing
  • Fertility Testing
  • Gonorrhea
  • Hiv
  • Hpv
  • Infectious Disease Testing
  • Myoglobin Testing
  • Other Cardiac Marker Testing
  • Other Clinical Tests
  • Other Sexually Transmitted Diseases
  • Pregnancy & Fertility Testing
  • Pregnancy Testing
  • Syphilis
  • Troponin I & T Testing

By Disease Type

  • Hepatitis
  • Influenza
  • Mosquito-Borne Diseases
  • Other Infectious Diseases
  • Sexually Transmitted Infection Testing
  • Tuberculosis

By Technique

  • Competitive Assays
  • Multiplex Detection Assays
  • Sandwich Assays

Target Audience

  • In Vitro Diagnostics Manufacturers : IVD companies seeking to expand in South Korea need detailed market sizing, growth projections, and competitive insights to develop localized product strategies and establish manufacturing or distribution partnerships.
  • Healthcare System Administrators : Hospital networks and healthcare providers in South Korea require market data to optimize diagnostic testing portfolios, evaluate lateral flow assay adoption ROI, and align procurement with clinical needs.
  • Medical Device Investors : Private equity and venture capital firms targeting South Korea's healthcare sector need comprehensive market analysis to identify investment opportunities and assess growth potential in the lateral flow assays segment.
  • Regulatory & Compliance Professionals : Regulatory affairs teams navigating South Korea's healthcare market need country-specific insights on market dynamics, regulatory pathways, and competitive standards to ensure compliant market entry.
  • Strategic Business Consultants : Management consulting firms advising clients on South Korea healthcare expansion require detailed market intelligence, growth drivers, and competitive positioning data to develop credible market strategies.

Reasons to Buy this Report

  • Market-Specific Sizing & Forecasts : Access precise valuation data for South Korea's lateral flow assays market (USD 71.3M in 2025) with detailed 5-year forecasts to inform investment and expansion strategies in this high-growth Asia Pacific market.
  • Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, regulatory requirements, and market entry barriers specific to the country's advanced healthcare ecosystem and quality-conscious consumer base.
  • Growth Driver Analysis : Identify key growth catalysts specific to South Korea including healthcare infrastructure investments, point-of-care testing adoption, and technological innovations driving the 6.1% CAGR through 2030.
  • Regional Market Positioning : Benchmark South Korea's lateral flow assays market performance against broader Asia Pacific trends, understanding the country's role as a premium diagnostic market and innovation leader in the region.
  • Strategic Decision Support : Enable data-driven decisions for market entry, product development, partnerships, and resource allocation tailored to South Korea's specific healthcare needs, regulatory environment, and demographic characteristics.

Frequently asked questions

What is the current market size of lateral flow assays in South Korea?

South Korea's lateral flow assays market is valued at USD 71.3 million in 2025.

What is the projected market size for lateral flow assays in South Korea by 2030?

South Korea's lateral flow assays market is projected to reach USD 96.0 million by 2030.

What is the CAGR for South Korea's lateral flow assays market?

South Korea's lateral flow assays market is expected to grow at a CAGR of 6.1% from 2025 to 2030.

What factors are driving growth in South Korea's lateral flow assays market?

South Korea's market growth is driven by increasing demand for rapid point-of-care testing, rising infectious disease prevalence, aging population demographics, and strong healthcare innovation infrastructure.

Why is South Korea significant in the Asia Pacific lateral flow assays market?

South Korea's advanced healthcare infrastructure, robust manufacturing capabilities, regulatory support for diagnostics, and export opportunities position it as a key regional hub for lateral flow assay development and distribution.

RESEARCH METHODOLOGY

The study focused on estimating the current market size of the global lateral flow assays market. Exhaustive secondary research was done to collect information on the lateral flow assays industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the lateral flow assays market.

The four steps involved in estimating the market size are:

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases, white papers, annual reports, investor presentations, SEC filings of companies, and publications from government sources [such as the US Food and Drug Administration, World Health Organization (WHO), ??Centers for Disease Control and Prevention, International Organization for Standardization (ISO), Agency for Healthcare Research and Quality] to identify and collect information for the global lateral flow assays market study. It was also used to obtain key information on players and market classification & segmentation, aligned with industry trends, down to the most granular level, along with key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from key companies and organizations in the lateral flow assays market. Primary demand-side sources include hospitals, clinics, diagnostic laboratories, and pharmaceutical and biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

Lateral Flow Assays Market
 Size, and Share

Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global lateral flow assays market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. The global lateral flow assays market was split into various segments and subsegments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of lateral flow assay providers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from lateral flow assays (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global lateral flow assays market

The above data was consolidated with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Lateral Flow Assays Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data were triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Lateral flow assays, or lateral flow immunochromatographic assays, are simple-to-use diagnostic devices to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals or contaminants in water supplies, without requiring specialized equipment.

Key Stakeholders

  • Lateral flow assays Product Manufacturers
  • Lateral flow assay vendors and distributors
  • Hospitals
  • Clinical and Diagnostic Laboratories
  • ??Pharmaceutical and Biotechnological Companies
  • Venture Capitalists and Investors

Report Objectives

  • To define, describe, analyze, and forecast the lateral flow assays (LFA) market by product, application, technique, sample type, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall lateral flow assays market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast market segment size across six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
  • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

Available customizations:

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the lateral flow assays market

Company profiles

  • Additional five company profiles of players operating in the lateral flow assays market

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the lateral flow assays market

 

Get the Full Lateral Flow Assays Market Report

Full forecast, segment splits, and company analysis for all Lateral Flow Assays Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status